Drug Database
Back to search

France· FR:66326694

ERAZABAN 100 mg/g, crème

A docosanol product containing docosanol, registered in France by PHOENIX HEALTHCARE (IRLANDE). The same ATC class is registered in 5 of our 19 countries.

ATC D06BB11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedERAZABAN 100 mg/g, crèmeATCD06BB11REGISTER NO.FR:66326694PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about docosanolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Docosanol is registered in 5 of 19 countries.

Countries holding a registration under ATC D06BB11 (docosanol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search docosanol products by name

Docosanol · ATC D06BB11

5 / 19 countries

  • Belgiumprice
  • Franceprice
  • Polandprice
  • Spainprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DOCOSANOL
Manufacturer
PHOENIX HEALTHCARE (IRLANDE)
Country
France (FR)
ATC code
D06BB11
ATC class
Docosanol
Defined daily dose
50 mg, T
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400938041538
    1 tube(s) aluminium verni de 2 g

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Docosanol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docosanol products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Erazaban
  • Belgium · Erazaban
  • United Kingdom (Northern Ireland) · Cold Sore, Docosanol Dendron Brands
  • Poland · Erazaban

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6eedc277-9b3f-4ed1-a777-2d4f1d2a3ae9
GET /v1/drugs/6eedc277-9b3f-4ed1-a777-2d4f1d2a3ae9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66326694",
  "date_amm": "2007-08-21",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "DOCOSANOL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "crème",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about docosanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console